$0.322500
0.00050.16%
At Close: -
$0.328800
0.00631.95%
After Hours: 7:59 PM EDT
15 minutes delayed
Sangamo Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Sangamo Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
SGMO | Sangamo Therapeutics | -$0.37 | — | — | — | $6.83M | — | — | — | 08/06/2024 | Get Alert |
SGMO | Sangamo Therapeutics | $0.12 | -$0.21 | -$0.27 | -28.57% | $157.96M | $6.65M | $481.00K | -92.77% | 05/09/2024 | Get Alert |
SGMO | Sangamo Therapeutics | -$0.32 | -$0.26 | -$0.34 | -30.77% | $27.23M | $8.10M | $2.04M | -74.79% | 03/13/2024 | Get Alert |
SGMO | Sangamo Therapeutics | -$0.34 | -$0.32 | -$0.59 | -84.38% | $26.46M | $10.40M | $9.40M | -9.63% | 11/01/2023 | Get Alert |
SGMO | Sangamo Therapeutics | -$0.29 | -$0.34 | -$0.37 | -8.82% | $29.38M | $14.83M | $6.83M | -53.91% | 08/08/2023 | Get Alert |
SGMO | Sangamo Therapeutics | -$0.30 | -$0.33 | $0.12 | 136.36% | $28.23M | $24.06M | $157.96M | 556.51% | 04/26/2023 | Get Alert |
SGMO | Sangamo Therapeutics | -$0.26 | -$0.36 | -$0.32 | 11.11% | $27.99M | $26.86M | $27.23M | 1.38% | 02/22/2023 | Get Alert |
SGMO | Sangamo Therapeutics | -$0.33 | -$0.35 | -$0.34 | 2.86% | $28.56M | $26.59M | $26.46M | -0.49% | 11/03/2022 | Get Alert |
SGMO | Sangamo Therapeutics | -$0.33 | -$0.35 | -$0.29 | 17.14% | $27.87M | $24.63M | $29.38M | 19.28% | 08/04/2022 | Get Alert |
SGMO | Sangamo Therapeutics | -$0.32 | -$0.31 | -$0.30 | 3.23% | $26.28M | $27.29M | $28.23M | 3.45% | 05/05/2022 | Get Alert |
SGMO | Sangamo Therapeutics | -$0.29 | -$0.34 | -$0.26 | 23.53% | $25.80M | $26.82M | $27.99M | 4.35% | 02/24/2022 | Get Alert |
SGMO | Sangamo Therapeutics | -$0.01 | -$0.34 | -$0.33 | 2.94% | $57.76M | $25.19M | $28.56M | 13.39% | 11/04/2021 | Get Alert |
SGMO | Sangamo Therapeutics | -$0.26 | -$0.31 | -$0.33 | -6.45% | $21.55M | $26.48M | $27.87M | 5.26% | 08/05/2021 | Get Alert |
SGMO | Sangamo Therapeutics | -$0.37 | -$0.30 | -$0.32 | -6.67% | $13.08M | $23.98M | $26.28M | 9.59% | 05/04/2021 | Get Alert |
SGMO | Sangamo Therapeutics | $0.04 | -$0.21 | -$0.29 | -38.10% | $54.85M | $32.15M | $25.80M | -19.75% | 02/24/2021 | Get Alert |
SGMO | Sangamo Therapeutics | -$0.24 | — | -$0.01 | — | $21.96M | — | $57.76M | — | 11/04/2020 | Get Alert |
SGMO | Sangamo Therapeutics | -$0.26 | — | -$0.26 | — | $17.55M | — | $21.55M | — | 08/05/2020 | Get Alert |
SGMO | Sangamo Therapeutics | -$0.41 | -$0.29 | -$0.37 | -27.59% | $8.07M | $22.74M | $13.08M | -42.50% | 05/11/2020 | Get Alert |
SGMO | Sangamo Therapeutics | -$0.18 | -$0.33 | $0.04 | 112.12% | $26.80M | — | $54.85M | — | 02/28/2020 | Get Alert |
SGMO | Sangamo Therapeutics | -$0.13 | -$0.34 | -$0.24 | 29.41% | $23.56M | $12.16M | $21.96M | 80.58% | 11/06/2019 | Get Alert |
SGMO | Sangamo Therapeutics | -$0.17 | -$0.36 | -$0.26 | 27.78% | $21.42M | $13.58M | $17.55M | 29.22% | 08/07/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $-0.27 | $-0.21 | -28.6 % |
Dec 2023 | 2024-03-13 | $-0.34 | $-0.26 | -30.8 % |
Sep 2023 | 2023-11-01 | $-0.59 | $-0.32 | -84.4 % |
Jun 2023 | 2023-08-08 | $-0.37 | $-0.34 | -8.82 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $481.00K | $6.65M | -92.8 % |
Dec 2023 | 2024-03-13 | $2.04M | $8.10M | -74.8 % |
Sep 2023 | 2023-11-01 | $9.40M | $10.40M | -9.63 % |
Jun 2023 | 2023-08-08 | $6.84M | $14.83M | -53.9 % |
Sangamo Therapeutics (SGMO) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
The Actual EPS was $-0.27, which missed the estimate of $-0.21.
The Actual Revenue was $481K, which missed the estimate of $6.7M.
Browse earnings estimates, EPS, and revenue on all stocks.